Anesthetics and Analgesics in Children
Launched by KANECIA OBIE ZIMMERMAN · Feb 8, 2018
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Anesthetics and Analgesics in Children," is designed to study how anesthetic and pain relief medications work in children and adolescents. Researchers want to understand how these drugs are processed in the body and ensure they are safe for young patients. The trial is currently looking for participants aged from newborns to under 18 years old. Eligible participants must be receiving specific medications as part of their medical care and must have a parent or guardian who can provide consent.
If you or your child join the study, you can expect to work closely with the research team, who will guide you through the process and answer any questions you may have. The study aims to gather important information that can help improve the use of these medications in young patients. It's important to note that children who are pregnant or have certain serious medical conditions may not be eligible for this trial. Overall, this study could contribute valuable insights into the safe use of anesthesia and pain relief in children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. 0 to \<18 years of age at time of enrollment (must see applicable appendix for details as not all appendices enroll across the entire age range)
- • 2. Parent and/or participant (if applicable) is able to understand the consent process and provides informed consent and HIPAA Authorization (if applicable)
- • 3. Participant provides assent as required by the institutional review board (IRB) or research ethics board (REB)
- • 4. Receiving one or more drugs of interest (DOI) per local standard of care
- • 5. Meeting DOI-specific inclusion criteria (See Appendices)
- Exclusion Criteria:
- • 1. Known pregnancy
- • 2. Extracorporeal life support (i.e., ECMO, dialysis, ventricular assist device)
- • 3. Any condition which would make the participant, in the opinion of the investigator, unsuitable for the study
About Kanecia Obie Zimmerman
Kanecia Obie Zimmerman is a distinguished clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a strong background in clinical medicine and a focus on innovative therapies, Zimmerman leads initiatives that prioritize ethical standards, regulatory compliance, and patient safety. Her expertise encompasses a wide range of therapeutic areas, and she is dedicated to fostering collaboration among researchers, clinicians, and stakeholders to drive the development of groundbreaking treatments. Under her guidance, clinical trials are conducted with rigor and integrity, ensuring that they contribute meaningful data to the scientific community and ultimately enhance healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Durham, North Carolina, United States
Charleston, South Carolina, United States
Nashville, Tennessee, United States
Saint Louis, Missouri, United States
Saint Louis, Missouri, United States
Wilmington, Delaware, United States
Portland, Oregon, United States
San Francisco, California, United States
Aurora, Colorado, United States
Toronto, Ontario, Canada
Albuquerque, New Mexico, United States
Houston, Texas, United States
Durham, North Carolina, United States
Stanford, California, United States
Montreal, Quebec, Canada
Chicago, Illinois, United States
Austin, Texas, United States
Patients applied
Trial Officials
Kanecia Zimmerman
Principal Investigator
Duke Clinical Research Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials